Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype.
Bal A, Casalegno JS, Melenotte C, Daviet F, Ninove L, Edouard S, Morfin F, Valette M, De Lamballerie X, Lina B, Papazian L, Nougairède A, Hraiech S. Bal A, et al. Among authors: de lamballerie x. Clin Microbiol Infect. 2020 Jul;26(7):947.e1-947.e4. doi: 10.1016/j.cmi.2020.03.010. Epub 2020 Mar 20. Clin Microbiol Infect. 2020. PMID: 32205296 Free article.
A French cohort for assessing COVID-19 vaccine responses in specific populations.
Loubet P, Wittkop L, Tartour E, Parfait B, Barrou B, Blay JY, Hourmant M, Lachâtre M, Laplaud DA, Laville M, Laviolle B, Lelievre JD, Morel J, Nguyen S, Spano JP, Terrier B, Thiebaut A, Viallard JF, Vrtovsnik F, de Lamballerie X, Launay O. Loubet P, et al. Among authors: de lamballerie x. Nat Med. 2021 Aug;27(8):1319-1321. doi: 10.1038/s41591-021-01435-1. Nat Med. 2021. PMID: 34253930 No abstract available.
Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal Antibodies.
Bailly B, Péré H, Veyer D, Berceanu A, Daguindau E, Roux P, Hermine O, de Lamballerie X, Bastard P, Lacombe K, Autran B, Angelot Delettre F, Laurent Casanova J, Imbeaud S, Laure Clairet A, Kroemer M, Spehner L, Robillard N, Puech J, Marty-Quinternet S, Lepiller Q, Chirouze C, Bouiller K. Bailly B, et al. Among authors: de lamballerie x. Clin Infect Dis. 2022 May 3;74(9):1706-1707. doi: 10.1093/cid/ciab868. Clin Infect Dis. 2022. PMID: 34598278 Free PMC article. No abstract available.
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D; Coverage Study Group. Duvignaud A, et al. Among authors: de lamballerie x. Clin Microbiol Infect. 2022 Jul;28(7):1010-1016. doi: 10.1016/j.cmi.2022.02.031. Epub 2022 Mar 15. Clin Microbiol Infect. 2022. PMID: 35304280 Free PMC article. Clinical Trial.
A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project.
Molino D, Durier C, Radenne A, Desaint C, Ropers J, Courcier S, Vieillard LV, Rekacewicz C, Parfait B, Appay V, Batteux F, Barillot E, Cogné M, Combadière B, Eberhardt CS, Gorochov G, Hupé P, Ninove L, Paul S, Pellegrin I, van der Werf S, Lefebvre M, Botelho-Nevers E, Ortega-Perez I, Jaspard M, Sow S, Lelièvre JD, de Lamballerie X, Kieny MP, Tartour E, Launay O. Molino D, et al. Among authors: de lamballerie x. Nat Med. 2022 May;28(5):882-884. doi: 10.1038/s41591-022-01785-4. Nat Med. 2022. PMID: 35513532 Free article. No abstract available.
Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial.
Janssen C, Cachanado M, Ninove L, Lachatre M, Michon J, Epaulard O, Maakaroun-Vermesse Z, Chidiac C, Laviolle B, Aumaitre H, Assaf A, Lacombe K, Schmidt-Mutter C, Botelho-Nevers E, Briere M, Boisson T, Loubet P, Bienvenu B, Bouchaud O, Touati A, Pereira C, Rousseau A, Berard L, Montil M, de Lamballerie X, Simon T, Launay O; ARNCOMBI Study Group. Janssen C, et al. Among authors: de lamballerie x. EClinicalMedicine. 2022 Jun;48:101444. doi: 10.1016/j.eclinm.2022.101444. Epub 2022 May 12. EClinicalMedicine. 2022. PMID: 35582124 Free PMC article.
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
Launay O, Cachanado M, Luong Nguyen LB, Ninove L, Lachâtre M, Ben Ghezala I, Bardou M, Schmidt-Mutter C, Lacombe K, Laine F, Allain JS, Botelho-Nevers E, Tavolacci MP, Chidiac C, Pavese P, Dussol B, Priet S, Deplanque D, Touati A, Curci L, Konate E, Ben Hamouda N, Besbes A, Nubret E, Capelle F, Berard L, Rousseau A, Tartour E, Simon T, de Lamballerie X. Launay O, et al. Among authors: de lamballerie x. N Engl J Med. 2022 Jul 28;387(4):374-376. doi: 10.1056/NEJMc2206711. Epub 2022 Jun 29. N Engl J Med. 2022. PMID: 35767474 Free PMC article. No abstract available.
A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox.
Luong Nguyen LB, Ghosn J, Durier C, Tachot C, Tartour E, Touati A, Simon T, Autran B, Ortega Perez I, Telford E, Ward JK, Michels D, Meyer L, Rousseau A, Berard L, de Lamballerie X, Launay O. Luong Nguyen LB, et al. Among authors: de lamballerie x. Nat Med. 2022 Oct;28(10):1983-1984. doi: 10.1038/d41591-022-00077-1. Nat Med. 2022. PMID: 35831633 No abstract available.
629 results